New research has found that Cannnabidiol is active against Gram-positive bacteria, including those responsible for many serious infections (such as Staphyloccocus aureus and Streptococcus pneumoniae), with potency similar to that of established antibiotics such as vancomycin or daptomycin.
The research is presented at ASM Microbe, the annual meeting of the American Society for Microbiology.
Cannabidiol, the main non-psychoactive chemical compound extracted from cannabis and hemp plants, has been approved by FDA for the treatment of a form of epilepsy, and is being investigated for a number of other medical conditions, including, anxiety, pain and inflammation. While there is limited data to suggest Cannabidiol can kill bacteria, the drug has not been thoroughly investigated for its potential as an antibiotic.
Work led by Dr Mark Blaskovich at The University of Queensland’s Institute for Molecular Bioscience’s Centre for Superbug Solutions, in collaboration with Botanix Pharmaceuticals Ltd, an early stage drug discovery company investigating topical uses of synthetic cannabidiol for a range of skin conditions, found that Cannabidiol was remarkably effective at killing a wide range of Gram-positive bacteria, including bacteria that have become resistant to other antibiotics, and did not lose effectiveness after extended treatment.
“Given cannabidiol’s documented anti-inflammatory effects, existing safety data in humans, and potential for varied delivery routes, it is a promising new antibiotic worth further investigation,” said Dr. Blaskovich. “The combination of inherent antimicrobial activity and potential to reduce damage caused by the inflammatory response to infections is particularly attractive.”
Importantly, the drug retained its activity against bacteria that have become highly resistant to other common antibiotics. Under extended exposure conditions that lead to resistance against vancomycin or daptomycin, Cannabidiol did not lose effectiveness. Cannabidiol was also effective at disrupting biofilms, a physical form of bacteria growth that leads to difficult-to-treat infections.
The project was co-funded by Botanix and Innovation Connections, an Australian government grant scheme to commercialize new products, processes and services. The paper will be presented on Sunday June 23rd from 11am-1 pm at the annual conference of the American Society for Microbiology, ASM Microbe 2019, at the Moscone Convention Center in San Francisco.
Learn more: Cannabidiol is a Powerful New Antibiotic
The Latest on: Cannnabidiol
via Google News
The Latest on: Cannnabidiol
- Considerations For Marketing Cannabis Amid Varied Lawson November 30, 2020 at 2:07 pm
As more states legalize cannabis and regulators take diverse approaches, general marketing compliance issues, such as avoiding false and misleading claims and ensuring the product reaches adults only, ...
- Cannabidiol Oil Market Size Is Expected To Reach US$ 41 billion by 2030on November 30, 2020 at 9:59 am
The global cannabidiol market size was estimated to be US$ 5.4 billion in 2019 and is expected to reach US$ 41 billion by 2030 at a CAGR of 20%. Cannabidiol Oil is a phytocannabin ...
- What are some of the top CBD products for energy?on November 30, 2020 at 9:00 am
Can CBD help boost energy? Read on to discover what current research says about CBD and energy and to find a list of CBD products people may consider trying.
- Cannabidiol Without A Prescription In Australia: Updateon November 30, 2020 at 8:33 am
TGA decision would be published last week in relation to over-the-counter cannabidiol (CBD) in Australia. Here’s what’s happening. First, a recap of the road to this point. Cannabidiol is a ...
- Cannabidiol(CBD) Water Market 2020 Global Analysis, Opportunities and Forecast to 2025on November 27, 2020 at 12:45 am
Wiseguyreports.Com Adds “Cannabidiol(CBD) Water -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025” To Its Research Database The research report includes ...
- Cannabidiol Oil (CBD Oil) Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027on November 25, 2020 at 12:29 pm
The Global Cannabidiol Oil (CBD Oil) Market is estimated to a register CAGR of over 20.6% during the forecast period 2020 to 2027. The research report on Cannabidiol Oil (CBD Oil) provide insights on ...
- Cannabidiol & Tetrahydrocannabinol Market by Future Growth Rate 2020-2026: NuLeaf Naturals, Plus CBD Oil, Green Roads and Canopy Growth Corporationon November 25, 2020 at 1:13 am
Global Cannabidiol & Tetrahydrocannabinol market 2020 incorporates the entire aspects of the Cannabidiol & Tetrahydrocannabinol market. This includes extensive analysis, recent industry statistics, ...
- Cannabidiol (CBD) Oil Market 2020 Industry Size, Share, Price, Trend and Forecast to 2025on November 24, 2020 at 1:46 am
Wiseguyreports.Com Adds “Cannabidiol (CBD) Oil -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025” To Its Research Database The global market for cannabidiol ...
- Cannabidiol Is Forbiddenon November 22, 2020 at 4:00 pm
In general, we say that what we know about this substance called cannabidiol is that it is a substance extracted from the hemp plant, and it is one of 113 identified cannabinoids in cannabis plants ...
- How Cannabidiol Can Help To Treat Arthritis Painon November 18, 2020 at 5:26 pm
With cannabidiol, it is possible to curb joint pain, inflammatory issues and movement-related problems. Arthritis symptoms such as reduced joint mobility, pain, and stiffness often respond ...
via Bing News